Hacettepe University
Ankara, 06100, Turkey (Türkiye)
NCT Number: NCT06516328
The goal of this observational study is to learn about some molecules in the disease mechanism of type 2 diabetes and periodontitis. There are end products inside the body called AGEs and their receptors binding to them especially (sRAGE, RAGE) in people with diabetes in hyperglycemic state.These molecules are important also in periodontitis (the disease of teeth that may end with exfoliation of the tooth). Diabetes and periodontitis enhance each other's disease-causing effects. Both is chronic inflammatory diseases and IL-17 is another molecule having role in this process.
Totally 64 men and women aged between 27-60 included in the study. Study groups were : 1.participants with healthy teeth and no diabetes, 2. participants with periodontitis without diabetes, 3.participants with periodontitis and controlled diabetes, 4.participants with periodontitis and uncontrolled diabetes (6.5% and fasting blood sugar levels <200 mg/dl). Researchers got saliva and gingival crevicular fluid (GCF) samples from diseased teeth and examined AGE, sRAGE, IL-17 levels. GCF is a fluid around the crevice of the theeth with different characteristics from saliva.
As a result AGE/sRAGE ratio and IL-17 levels of diseased groups were higher than healthy group, while sRAGE levels were significantly lower in GCF samples. Researchers concluded that GCF and saliva AGE/sRAGE ratio may represent as a biomarker in periodontitis patients with uncontrolled diabetes.
Looking for future studies?
Notify Me25 year–74 year
All sexes
Observational
Ankara, 06100, Turkey (Türkiye)
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
GCF and saliva samples obtained.
Time frame: 3 to 6 months
AGEs to RAGE ratio comparison between study groups
Time frame: 3 to 6 months
IL-17 level comparison between study groups
Hacettepe University
Other
AGE/sRAGE and IL-17 Levels in Type 2 Diabetic Periodontitis Patients
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07298057
Diabetes Mellitus, Diabetes Mellitus, Type 2
Cleveland, Ohio, United States
View Trial DetailsNCT07691060
Arachnodactyly, Congenital Abnormalities
Ankara, Turkey (Türkiye)
View Trial DetailsNCT07498894
Diabetes Complications, Diabetes Mellitus
Denizli, Turkey (Türkiye)
View Trial DetailsNCT06941246
Diabetes Mellitus, Diabetes Mellitus, Type 2
Cairo, Egypt
View Trial Details